| Diagnosis, treatment, and long-term management of Kawasaki disease: a scientific statement for health professionals from the American Heart Association BW McCrindle, AH Rowley, JW Newburger, JC Burns, AF Bolger, ... circulation 135 (17), e927-e999, 2017 | 3305 | 2017 |
| Prediction of intravenous immunoglobulin unresponsiveness in patients with Kawasaki disease T Kobayashi, Y Inoue, K Takeuchi, Y Okada, K Tamura, T Tomomasa, ... Circulation 113 (22), 2606-2612, 2006 | 935 | 2006 |
| Efficacy of immunoglobulin plus prednisolone for prevention of coronary artery abnormalities in severe Kawasaki disease (RAISE study): a randomised, open-label, blinded … T Kobayashi, T Saji, T Otani, K Takeuchi, T Nakamura, H Arakawa, T Kato, ... The Lancet 379 (9826), 1613-1620, 2012 | 717 | 2012 |
| A genome-wide association study identifies three new risk loci for Kawasaki disease Y Onouchi, K Ozaki, JC Burns, C Shimizu, M Terai, H Hamada, T Honda, ... Nature genetics 44 (5), 517-521, 2012 | 343 | 2012 |
| JCS/JSCS 2020 guideline on diagnosis and management of cardiovascular sequelae in Kawasaki disease R Fukazawa, J Kobayashi, M Ayusawa, H Hamada, M Miura, Y Mitani, ... Circulation Journal 84 (8), 1348-1407, 2020 | 251 | 2020 |
| A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome Y Inoue, Y Okada, M Shinohara, T Kobayashi, T Kobayashi, T Tomomasa, ... The Journal of pediatrics 149 (3), 336-341. e1, 2006 | 206 | 2006 |
| A new Z score curve of the coronary arterial internal diameter using the lambda-mu-sigma method in a pediatric population T Kobayashi, S Fuse, N Sakamoto, M Mikami, S Ogawa, K Hamaoka, ... Journal of the American Society of Echocardiography 29 (8), 794-801. e29, 2016 | 190 | 2016 |
| Effect of corticosteroids in addition to intravenous gamma globulin therapy on serum cytokine levels in the acute phase of Kawasaki disease in children Y Okada, M Shinohara, T Kobayashi, Y Inoue, T Tomomasa, T Kobayashi, ... The Journal of pediatrics 143 (3), 363-367, 2003 | 177 | 2003 |
| Revision of diagnostic guidelines for Kawasaki disease . T Kobayashi, M Ayusawa, H Suzuki, J Abe, S Ito, T Kato, M Kamada, ... Pediatrics international 62 (10), 2020 | 159 | 2020 |
| NUP98‐NSD1 gene fusion and its related gene expression signature are strongly associated with a poor prognosis in pediatric acute myeloid leukemia N Shiba, H Ichikawa, T Taki, MJ Park, A Jo, S Mitani, T Kobayashi, ... Genes, Chromosomes and Cancer 52 (7), 683-693, 2013 | 119 | 2013 |
| Ulinastatin, a urinary trypsin inhibitor, for the initial treatment of patients with Kawasaki disease: a retrospective study T Kanai, T Ishiwata, T Kobayashi, H Sato, M Takizawa, Y Kawamura, ... Circulation 124 (25), 2822-2828, 2011 | 112 | 2011 |
| Autism spectrum disorder and prenatal exposure to selective serotonin reuptake inhibitors: A systematic review and meta-analysis T Kobayashi, T Matsuyama, M Takeuchi, S Ito Reproductive Toxicology 65, 170-178, 2016 | 108 | 2016 |
| Association of severity of coronary artery aneurysms in patients with Kawasaki disease and risk of later coronary events M Miura, T Kobayashi, T Kaneko, M Ayusawa, R Fukazawa, N Fukushima, ... JAMA pediatrics 172 (5), e180030-e180030, 2018 | 107 | 2018 |
| Coronary artery outcomes among children with Kawasaki disease in the United States and Japan S Ogata, AH Tremoulet, Y Sato, K Ueda, C Shimizu, X Sun, S Jain, ... International journal of cardiology 168 (4), 3825-3828, 2013 | 99 | 2013 |
| Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease T Kobayashi, T Kobayashi, A Morikawa, K Ikeda, M Seki, S Shimoyama, ... The Journal of pediatrics 163 (2), 521-526. e1, 2013 | 99 | 2013 |
| Measurement of tricuspid annular diastolic velocities by Doppler tissue imaging to assess right ventricular function in patients with congenital heart disease M Watanabe, S Ono, T Tomomasa, Y Okada, T Kobayashi, T Suzuki, ... Pediatric cardiology 24, 463-467, 2003 | 89 | 2003 |
| Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta‐analysis M Tanoshima, T Kobayashi, R Tanoshima, J Beyene, G Koren, S Ito Clinical Pharmacology & Therapeutics 98 (4), 417-441, 2015 | 87 | 2015 |
| Risk stratification in the decision to include prednisolone with intravenous immunoglobulin in primary therapy of Kawasaki disease T Kobayashi, Y Inoue, T Otani, A Morikawa, T Kobayashi, K Takeuchi, ... The Pediatric infectious disease journal 28 (6), 498-502, 2009 | 87 | 2009 |
| Nationwide survey of systemic chronic active EBV infection in Japan in accordance with the new WHO classification I Yonese, C Sakashita, KI Imadome, T Kobayashi, M Yamamoto, ... Blood advances 4 (13), 2918-2926, 2020 | 68 | 2020 |
| TNF‐α blockers for the treatment of Kawasaki disease in children N Yamaji, K da Silva Lopes, T Shoda, K Ishitsuka, T Kobayashi, E Ota, ... Cochrane Database of Systematic Reviews, 2019 | 67 | 2019 |
